Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Clinical trial NCT04375098 · COMPLETED

Trial details

NCT number: NCT04375098
Sponsor: Pontificia Universidad Catolica de Chile
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2

Start date: 2020-05-04
Primary completion: 2020-08-17
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.